Published in Neuroimage on August 29, 2005
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature (2009) 4.43
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol (2009) 2.85
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci (2008) 2.15
Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol (2011) 1.91
Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage (2009) 1.85
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology (2006) 1.78
Heart failure and Alzheimer's disease. J Intern Med (2014) 1.54
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol (2010) 1.35
The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci (2012) 1.29
ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord (2010) 1.26
Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab (2011) 1.18
Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J Neurol (2007) 1.16
Specifically progressive deficits of brain functional marker in amnestic type mild cognitive impairment. PLoS One (2011) 1.11
Predicting the brain response to treatment using a Bayesian hierarchical model with application to a study of schizophrenia. Hum Brain Mapp (2008) 1.05
Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab (2010) 0.97
Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J Alzheimers Dis (2012) 0.96
Altered connectivity pattern of hubs in default-mode network with Alzheimer's disease: an Granger causality modeling approach. PLoS One (2011) 0.96
Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol (2008) 0.95
Aberrant hippocampal subregion networks associated with the classifications of aMCI subjects: a longitudinal resting-state study. PLoS One (2011) 0.89
Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer's disease. Front Behav Neurosci (2014) 0.89
Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone. J Cereb Blood Flow Metab (2010) 0.88
Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis (2010) 0.87
A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis (2012) 0.87
L-arginine and Alzheimer's disease. Int J Clin Exp Pathol (2008) 0.87
Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease. J Cereb Blood Flow Metab (2014) 0.86
(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. Am J Geriatr Psychiatry (2010) 0.83
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci (2017) 0.82
Capillary dysfunction: its detection and causative role in dementias and stroke. Curr Neurol Neurosci Rep (2015) 0.81
Statistical approaches to functional neuroimaging data. Neuroimaging Clin N Am (2007) 0.81
Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients. J Cereb Blood Flow Metab (2016) 0.79
Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease. J Neural Transm (Vienna) (2015) 0.79
Sex Differences in Presynaptic Density and Neurogenesis in Middle-Aged ApoE4 and ApoE Knockout Mice. J Neurodegener Dis (2013) 0.78
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations. Cell Mol Neurobiol (2015) 0.78
Neuroimaging in dementia. Semin Neurol (2008) 0.78
Age-related alteration in cerebral blood flow and energy failure is correlated with cognitive impairment in the senescence-accelerated prone mouse strain 8 (SAMP8). Neurol Sci (2013) 0.78
Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment. J Alzheimers Dis (2014) 0.78
Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease. Neurobiol Aging (2006) 0.78
Simultaneous Tc-99m and I-123 dual-radionuclide imaging with a solid-state detector-based brain-SPECT system and energy-based scatter correction. EJNMMI Phys (2016) 0.78
Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study. Ann Nucl Med (2013) 0.77
Association of the interleukin 1 beta gene and brain spontaneous activity in amnestic mild cognitive impairment. J Neuroinflammation (2012) 0.77
Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy. Cell Mol Neurobiol (2016) 0.76
Retinal blood flow in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (Amst) (2015) 0.76
Emerging biomarkers in cognition. Clin Geriatr Med (2013) 0.76
Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice. Sci Rep (2016) 0.75
Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice. Theranostics (2017) 0.75
Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease. Neurobiol Aging (2016) 0.75
Isometric Exercise Training for Managing Vascular Risk Factors in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Hemodynamic effects of combined focal cerebral ischemia and amyloid protein toxicity in a rat model: a functional CT study. PLoS One (2014) 0.75
Magnetic Resonance Q Mapping Reveals a Decrease in Microvessel Density in the arcAβ Mouse Model of Cerebral Amyloidosis. Front Aging Neurosci (2016) 0.75
The neuroimaging approach to the assessment of mild cognitive impairment. Eur J Nucl Med Mol Imaging (2006) 0.75
Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion. Nat Genet (2005) 2.77
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell (2013) 2.32
Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. Biol Psychiatry (2008) 2.06
Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med (2009) 1.96
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology (2002) 1.93
Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett (2005) 1.86
Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet (2006) 1.82
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging (2009) 1.77
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2005) 1.65
Virtual monochromatic spectral imaging with fast kilovoltage switching: improved image quality as compared with that obtained with conventional 120-kVp CT. Radiology (2011) 1.63
IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol (2008) 1.59
Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur J Nucl Med Mol Imaging (2007) 1.58
Empathy and judging other's pain: an fMRI study of alexithymia. Cereb Cortex (2006) 1.58
Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias. J Am Coll Cardiol (2005) 1.56
Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med (2002) 1.48
A voxel-based morphometry study of frontal gray matter correlates of impulsivity. Hum Brain Mapp (2009) 1.48
Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease. Cardiovasc Res (2011) 1.46
Plasma brain natriuretic peptide levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation. Circ J (2007) 1.44
Diagnostic capacity of 64-slice multidetector computed tomography for acute coronary syndrome in patients presenting with acute chest pain. Cardiology (2008) 1.42
Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med (2009) 1.42
Circadian rhythms and the effect of glucocorticoids on expression of the clock gene period1 in canine peripheral blood mononuclear cells. Vet J (2012) 1.41
Quantitative regional blood flow measurements in exercising leg skeletal muscle based on 99mTc-pertechnetate clearance. Nucl Med Commun (2008) 1.39
Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res (2007) 1.39
Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet (2011) 1.38
Age-related degeneration of corpus callosum measured with diffusion tensor imaging. Neuroimage (2006) 1.38
Reliability and validity of gait analysis by android-based smartphone. Telemed J E Health (2012) 1.33
Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun (2002) 1.32
Mitochondrial DNA divergence in populations of the tapeworm Diphyllobothrium nihonkaiense and its phylogenetic relationship with Diphyllobothrium klebanovskii. Parasitol Int (2008) 1.29
Impaired self-awareness and theory of mind: an fMRI study of mentalizing in alexithymia. Neuroimage (2006) 1.28
Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Hum Mol Genet (2006) 1.27
Specific brain activation in Japanese and Caucasian people to fearful faces. Neuroreport (2005) 1.26
An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol (2006) 1.24
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS One (2011) 1.23
Changes of brain activity in the neural substrates for theory of mind during childhood and adolescence. Psychiatry Clin Neurosci (2007) 1.23
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23
Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J (2009) 1.22
A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol (2008) 1.22
Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2010) 1.20
Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport (2005) 1.20
The empathic brain and its dysfunction in psychiatric populations: implications for intervention across different clinical conditions. Biopsychosoc Med (2007) 1.20
Diphyllobothriasis associated with eating raw pacific salmon. Emerg Infect Dis (2009) 1.19
Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol (2002) 1.19
The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett (2006) 1.18
Tubulin seeds alpha-synuclein fibril formation. J Biol Chem (2001) 1.18
Diffusion abnormalities of the uncinate fasciculus in Alzheimer's disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract. Neuroradiology (2008) 1.17
Prevalence and causes of early-onset dementia in Japan: a population-based study. Stroke (2009) 1.15
Genetic association of CTNNA3 with late-onset Alzheimer's disease in females. Hum Mol Genet (2007) 1.15
Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology (2007) 1.14
Evening preference is related to the incidence of depressive states independent of sleep-wake conditions. Chronobiol Int (2010) 1.13
Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci Res (2008) 1.12
Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics (2009) 1.12
Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry (2005) 1.11
Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet (2005) 1.11
Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT. Eur J Nucl Med Mol Imaging (2004) 1.11
Clinical analyses of sighted patients with non-24-hour sleep-wake syndrome: a study of 57 consecutively diagnosed cases. Sleep (2005) 1.11
Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. Dement Geriatr Cogn Disord (2008) 1.10
Diphyllobothriasis nihonkaiense: possibly acquired in Switzerland from imported Pacific salmon. Intern Med (2008) 1.10